{
    "organizations": [],
    "uuid": "79bd200a6c50f7ec3db38bef18cee98e36299d91",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fountain-biopharma-anti-cmx-antibo/brief-fountain-biopharma-anti-cmx-antibody-receives-europe-patent-idUSL4N1QB2EV",
    "ord_in_thread": 0,
    "title": "BRIEF-Fountain Biopharma anti-CεmX antibody receives Europe Patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - Fountain Biopharma Inc :\n* Says its anti-CεmX antibody FB825 received Europe patent, for Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes\n* Patent number is EP2401300B1\nSource text in Chinese: goo.gl/2aXnuz\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-21T17:55:00.000+02:00",
    "crawled": "2018-02-22T18:05:09.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "fountain",
        "biopharma",
        "inc",
        "say",
        "antibody",
        "fb825",
        "received",
        "europe",
        "patent",
        "antibody",
        "capable",
        "binding",
        "human",
        "mige",
        "b",
        "lymphocyte",
        "patent",
        "number",
        "ep2401300b1",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}